-
公开(公告)号:US20090317331A1
公开(公告)日:2009-12-24
申请号:US12435176
申请日:2009-05-04
IPC分类号: A61K31/7076 , A61K49/00
CPC分类号: C07H19/16 , A61K51/00 , G01N33/5008 , G01N33/502 , G01N33/5082 , G01N33/5088 , G01N33/566 , G01N2500/04
摘要: The present invention provides a method for identifying and using partial adenosine A2A receptor agonists that are useful as adjuncts in myocardiological perfusion imaging.
摘要翻译: 本发明提供了用于鉴定和使用可用作心肌灌注成像辅助剂的部分腺苷A2A受体激动剂的方法。
-
公开(公告)号:US07521554B2
公开(公告)日:2009-04-21
申请号:US11508592
申请日:2006-08-22
申请人: Elfatih Elzein , Rao Kalla , Tim Marquart , Jeff Zablocki , Xiaofen Li
发明人: Elfatih Elzein , Rao Kalla , Tim Marquart , Jeff Zablocki , Xiaofen Li
IPC分类号: C07D239/54 , C07D403/12
CPC分类号: C07D473/06 , C07D239/545 , C07D403/12 , C07D473/00 , C07D473/08
摘要: Disclosed are processes for the synthesis of novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.
摘要翻译: 公开了用于合成可用于治疗各种疾病状态(包括哮喘和腹泻)的A2B腺苷受体拮抗剂的新化合物的方法。
-
公开(公告)号:US07488720B2
公开(公告)日:2009-02-10
申请号:US11546658
申请日:2006-10-11
申请人: Elfatih Elzein , Xiaofen Li , Jeff Zablocki
发明人: Elfatih Elzein , Xiaofen Li , Jeff Zablocki
IPC分类号: A01N43/04 , A61K31/70 , C07H19/00 , C07H19/167 , C07H19/173
CPC分类号: C07H19/16 , C07D473/00
摘要: Disclosed are novel compounds that are A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, diseases related to release of nonesterified fatty acids, and myocardial infarction.
摘要翻译: 公开了可用于治疗各种疾病状态,特别是心动过速和心房扑动,心绞痛,与非酯化的脂肪酸释放有关的疾病和心肌梗死的A1腺苷受体激动剂的新化合物。
-
公开(公告)号:US07317017B2
公开(公告)日:2008-01-08
申请号:US11189202
申请日:2005-07-25
申请人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: C07D473/12 , C07D473/06 , C07D473/04 , A61K51/522 , A61P11/06
CPC分类号: C07D473/06 , A61K31/522 , C07D473/04
摘要: Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
摘要翻译: 公开了具有式I或式II结构的新型Aβ2 N 2腺苷受体拮抗剂。该化合物特别可用于治疗哮喘,炎症性胃肠道疾病,心血管疾病,神经障碍和与不期望的血管生成有关的疾病 。
-
公开(公告)号:US20070207978A1
公开(公告)日:2007-09-06
申请号:US11522120
申请日:2006-09-15
申请人: Jeff Zablocki , Elfatih Elzein , Venkata Palle
发明人: Jeff Zablocki , Elfatih Elzein , Venkata Palle
IPC分类号: A61K31/708 , A61K31/415 , C07D231/10 , C07H19/173 , C07D473/34 , A61K31/52
CPC分类号: C07H19/16
摘要: 2-adenosine C-pyrazole compounds having formula (a) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.
摘要翻译: 具有式(a)的2-腺苷C-吡唑化合物和使用该化合物作为A2A受体激动剂的方法,用于刺激哺乳动物冠状血管扩张用于治疗目的和用于成像心脏的目的。
-
公开(公告)号:US07205303B2
公开(公告)日:2007-04-17
申请号:US10745224
申请日:2003-12-19
申请人: Venkata Palle , Jeff Zablocki
发明人: Venkata Palle , Jeff Zablocki
IPC分类号: A61K31/495 , C07D295/15
CPC分类号: C07D295/15 , C07D231/56 , C07D277/62 , C07D277/82 , C07D401/04
摘要: Disclosed are novel heterocyclic compounds having the structure which are useful for the treatment of various disease states, m particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
摘要翻译: 公开了具有该结构的新型杂环化合物
-
公开(公告)号:US07163928B2
公开(公告)日:2007-01-16
申请号:US10770542
申请日:2004-02-02
申请人: Gloria Cristalli , Venkata Palle , Jeff Zablocki
发明人: Gloria Cristalli , Venkata Palle , Jeff Zablocki
IPC分类号: A01N43/04 , A61K31/70 , C07H19/00 , C07H19/22 , C07H19/167
CPC分类号: C07D473/00
摘要: Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
摘要翻译: 公开了可用于治疗各种疾病状态,特别是心动过速和心房扑动,心绞痛和心肌梗死的部分和全部A 1 N 2腺苷受体激动剂的新化合物。
-
公开(公告)号:US07157440B2
公开(公告)日:2007-01-02
申请号:US10855471
申请日:2004-05-27
CPC分类号: A61K31/7076 , C07D473/16 , C07H19/16
摘要: Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.
-
公开(公告)号:US07125993B2
公开(公告)日:2006-10-24
申请号:US10719102
申请日:2003-11-21
申请人: Elfatih Elzein , Rao Kalla , Tim Marquart , Jeff Zablocki , Xiaofen Li
发明人: Elfatih Elzein , Rao Kalla , Tim Marquart , Jeff Zablocki , Xiaofen Li
IPC分类号: C07D473/04 , C07D473/06 , C07D473/08 , C07D247/02 , C07D239/545
CPC分类号: C07D473/06 , C07D239/545 , C07D403/12 , C07D473/00 , C07D473/08
摘要: Disclosed are processes for the synthesis of novel compounds that are A2B adenosine receptor antagonists, having the structure of Formula I or Formula II: by cyclizing a compound of the formula (3):
摘要翻译: 公开了具有式I或式II结构的通过使式(3)的化合物环化合成作为A 2 B 2腺苷受体拮抗剂的新化合物的方法:
-
公开(公告)号:US07105665B2
公开(公告)日:2006-09-12
申请号:US10947708
申请日:2004-09-23
申请人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
发明人: Rao Kalla , Thao Perry , Elfatih Elzein , Vaibhav Varkhedkar , Xiaofen Li , Prabha Ibrahim , Venkata Palle , Dengming Xiao , Jeff Zablocki
IPC分类号: C07D473/04 , C07D473/06 , C07D473/08 , A61K31/522 , A61P9/10
CPC分类号: C07D473/00 , C07D473/06 , C07D473/08
摘要: Disclosed are methods for making novel A2B adenosine receptor antagonists having the structure of formula I or Formula II: The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
摘要翻译: 公开的是制备具有式I或式II结构的新的Aβ2A腺苷受体拮抗剂的方法:该化合物特别可用于治疗哮喘,炎性胃肠道疾病,心血管疾病,神经障碍和疾病 与不良血管生成有关。
-
-
-
-
-
-
-
-
-